92 related articles for article (PubMed ID: 17549377)
21. HER2 and EGFR expression in cutaneous spindle squamous cell carcinoma.
Schlauder SM; Calder KB; Moody P; Morgan MB
Am J Dermatopathol; 2007 Dec; 29(6):559-63. PubMed ID: 18032952
[TBL] [Abstract][Full Text] [Related]
22. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T
Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172
[TBL] [Abstract][Full Text] [Related]
23. Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.
Fink-Retter A; Gschwantler-Kaulich D; Hudelist G; Mueller R; Kubista E; Czerwenka K; Singer CF
Oncol Rep; 2007 Aug; 18(2):299-304. PubMed ID: 17611648
[TBL] [Abstract][Full Text] [Related]
24. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification.
Elliott DD; Sherman SI; Busaidy NL; Williams MD; Santarpia L; Clayman GL; El-Naggar AK
Hum Pathol; 2008 Jan; 39(1):15-20. PubMed ID: 17949783
[TBL] [Abstract][Full Text] [Related]
25. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
26. Expression of epiregulin, a novel epidermal growth factor ligand associated with prognosis in human oral squamous cell carcinomas.
Shigeishi H; Higashikawa K; Hiraoka M; Fujimoto S; Mitani Y; Ohta K; Takechi M; Kamata N
Oncol Rep; 2008 Jun; 19(6):1557-64. PubMed ID: 18497965
[TBL] [Abstract][Full Text] [Related]
27. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
Cornolti G; Ungari M; Morassi ML; Facchetti F; Rossi E; Lombardi D; Nicolai P
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
[TBL] [Abstract][Full Text] [Related]
28. [Detection of tumor necrosis factor mRNA expression in human cervix and endometrium by in situ hybridization].
Ding SY; Wu R
Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):244-6. PubMed ID: 12390778
[TBL] [Abstract][Full Text] [Related]
29. Expression of organic cation transporter SLC22A16 in human endometria.
Sato N; Ito K; Onogawa T; Akahira J; Unno M; Abe T; Niikura H; Yaegashi N
Int J Gynecol Pathol; 2007 Jan; 26(1):53-60. PubMed ID: 17197897
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
[TBL] [Abstract][Full Text] [Related]
31. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung.
Sartori G; Bettelli S; Schirosi L; Bigiani N; Maiorana A; Cavazza A; Rossi G
Am J Surg Pathol; 2007 Oct; 31(10):1512-20. PubMed ID: 17895751
[TBL] [Abstract][Full Text] [Related]
32. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors.
Flint AF; U'Ren L; Legare ME; Withrow SJ; Dernell W; Hanneman WH
Vet Pathol; 2004 May; 41(3):291-6. PubMed ID: 15133183
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and c-erbB-2 (HER2/neu) overexpression status in primary breast cancer patients: an analysis of 158 needle core biopsies.
Vameşu S
Rom J Morphol Embryol; 2007; 48(2):121-9. PubMed ID: 17641798
[TBL] [Abstract][Full Text] [Related]
36. Altered transforming growth factor-beta pathway expression pattern in rat endometrial cancer.
Karlsson S; Holmberg E; Askerlund A; Levan KK
Cancer Genet Cytogenet; 2007 Aug; 177(1):43-50. PubMed ID: 17693190
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
[TBL] [Abstract][Full Text] [Related]
38. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus].
Yue Y; Piao JX; Wang LN; Pu JW; Gao FD
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189
[TBL] [Abstract][Full Text] [Related]
39. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
